How Much Does a Course of GS-441524 (NeoFipronis) Treatment Cost
Feline Infectious Peritonitis (FIP) remains one of the most challenging and deadly diseases affecting cats worldwide. Traditionally considered nearly incurable, recent breakthroughs have introduced targeted antiviral therapies, dramatically changing the prognosis for affected cats. NeoFipronis (Pronidesivir), containing the active ingredient GS-441524, has become a revolutionary treatment option for FIP, offering high efficacy, safety, and ease of administration.
GS-441524 is a nucleoside analog proven to inhibit the replication of feline coronavirus, which causes FIP. NeoFipronis, officially approved by the Laos Ministry of Agriculture and Forestry in March 2026, is the world's first orally administered, officially registered FIP medication. It boasts rapid absorption, minimal side effects, and remarkable therapeutic outcomes. Its approval marks a significant milestone in veterinary medicine, providing pet owners and veterinarians with a reliable treatment solution.
The drug is designed for oral use, with dosing tailored to the cat’s weight. The standard protocol involves administering 15 mg per kilogram of body weight daily, roughly half a tablet, ideally on an empty stomach—one hour before or two hours after feeding. For neurovisceral or ocular FIP types, the dosage may be increased under veterinary supervision to 30 mg/kg to ensure comprehensive viral suppression. Treatment duration should last no less than 12 weeks, with consistent administration and monitoring for potential side effects or changes in health status.
NeoFipronis’s safety profile is highly favorable. It is non-invasive, well-tolerated by most cats, and causes minimal adverse reactions. Regular veterinary check-ups are essential during treatment to assess blood work, liver and kidney function, and overall health. Owners are advised to observe their cats closely for appetite, temperature, and activity level changes. Discontinuing therapy prematurely can lead to relapse, so adherence to the prescribed course is critical.
Cost is a common concern for pet owners considering FIP treatment. The overall expense depends on several factors: the cat’s weight, the duration of therapy, and regional pricing differences. On average, a four-week supply of NeoFipronis may cost between $300 and $600. A full 12-week course, necessary for effective viral clearance, typically ranges from $900 to $1800. These estimates include medication and veterinary supervision, but prices can vary based on the supplier, geographic location, and additional veterinary services.
Despite the initial investment, many owners find the cost justified by the exceptional remission rates and improved quality of life for their cats. Given the historically grim outlook for FIP, NeoFipronis offers a new lease on life, transforming the disease into a manageable condition during treatment.
Customers should only purchase NeoFipronis from official sources such as the dedicated NeoFipronis website to guarantee product authenticity and quality. While it is available without a prescription, veterinary guidance is highly recommended to optimize treatment outcomes and ensure safety.
In summary, the cost of treating feline infectious peritonitis with NeoFipronis depends on dosing, duration, and regional pricing, but the investment is often outweighed by the potential for complete recovery. As a pioneering oral medication with proven efficacy, NeoFipronis represents a game-changer in veterinary medicine, offering hope for cats diagnosed with FIP and peace of mind for their owners.
